Evaluating the quality of longitudinal statistical applications in original publications on Alzheimer's disease

Neuroepidemiology

Volumn 30, Issue 2, 2008, Pages 112-119

  Xiong, Chengjie ^a,b   Tang, Yuxiao ^c   Van Belle, Gerald ^c   Miller, J Philip ^a   Launer, Lenore J ^d   Morris, John C ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease, longitudinal studies; Cognition; Neurodegenerative disease; Reliability coefficient

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BIOSTATISTICS; CORRELATION COEFFICIENT; TEST RETEST RELIABILITY;

AGED; ALZHEIMER DISEASE; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; OBSERVER VARIATION; PUBLICATIONS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 41849119069     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120024     Document Type: Article

References (38)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
2. Rentz DM, Huh TJ, Faust RR, et al: Use of IC-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 2004;18:38-49.
3. Peterson RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairnment. Arch Neurol 2001;58:1985-1992.
4. Diggle PJ, Heagerty P, Liang K-Y, et al: Analysis of Longitudinal Data, ed 2. New York, Oxford University Press, 2002.
5. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. Hoboken, Wiley, 2004.
6. Verbeke G, Molenberghs G: Linear Mixed Models for Longitudinal Data. New York, Springer, 2000.
7. Singer JD, Willett JB: Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, Oxford University Press, 2003.
8. Molenberghs G, Verbeke G: Models for Discrete Longitudinal Data. New York, Springer, 2005.
9. Xiong C, Tang Y, van Belle G, Miller JP, Launer LJ, Bergmann KR, Morris JC: Assessing statistical applications in publications on Alzheimer's disease. Neuroepidemiology 2007;28:235-245.
10. Little RJA, Rubin DB: Statistical Analysis with Missing Data, ed 2. New York, Wiley, 2002.
11. Wu MC, Bailey KR: Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics 1988;45:939-955.
12. Wu MC, Carroll RJ: Estimation and comparison of changes in the presence of right censoring by modeling the censoring process. Biometrics 1988;44:175-188.
13. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, Wiley, 1980.
14. Storandt M, Grant EA, Miller JP, et al: Rates of progression in mild cognitive impairment and early Alzheimer disease. Neurology 2002;59:1034-1041.
15. Mohs RC, Schmeidler J, Aryan M: Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Stat Med 2000;19:1401-1409.
16. Galasko DR, Gould RL, Abramson IS, Salmon DP: Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med 2000;19:1421-1432.
17. Zonderman AB, Giambra LM, Arenberg D, Resnick SM, Costa PT Jr, Kawas CH: Changes in immediate visual memory predict cognitive impairment. Arch Clin Neuropsychol 1995;10:111-123.
18. Tierney MC, Szalai JP, Snow WG, et al: Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661-665.
19. Marquis S, Moore MM, Howieson DB, et al: Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002;59:601-606.
20. Launer L: Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence. Drugs 2003;63:731-739.
21. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-1414.
22. Xiong C, Zhu K, Yu K, Miller JP: Statistical modeling in biomedical research: longitudinal data analysis; in Rao CR, Miller JP, Rao DC (eds): Handbook of Statistics. Amsterdam, Elsevier, 2007, pp 429-463.
23. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model. New York, Springer, 2000.
24. Schoenfeld D: Chi-squared goodness-of-fit tests for the proportional hazards model. Biometrika 1980;67:145-153.
25. SAS Institute, Inc: SAS Language (Version 8), Cary, SAS Institute, 1999.
26. Spitzer R, Cohen J, Fleiss J, Endicott J: Quantification of agreement in psychiatry diagnosis: a new approach. Arch Gen Psychiatry 1967;17:83-87.
27. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;2:420-428.
28. McGraw KO, Wong SP: Forming inferences about some intraclass correlation coefficients. Psychol Meth 1996;1:30-46.
29. Agresti A: Categorical Data Analysis. New York, Wiley, 1990.
30. Moher D, Jadad AR, Nichol G, et al: Assessing the quality of randomized controlled trials: an annotated bibliography of checklists. Control Clin Trials 1995;16:62-73.
31. Lionel NDW, Herxheimer A: Assessing reports of therapeutical trials. BMJ 1970;3:637-640.
32. Badgley RF: An assessment of research methods reported in 103 scientific articles from two Canadian medical journals. Can Med Assoc J 1961;85:246-251.
33. Thomson ME, Kramer MS: Methodological standards for controlled clinical trials of early contact and maternal-infant behaviour. Pediatrics 1984;73:294-300.
34. Mosteller F, Gilbert JP, McPeek B: Reporting standards and research strategies for controlled trials: agenda for the editor. Control Clin Trials 1980;1:37-58.
35. Sacks HS, Berrier J, Reitman D, et al: Meta-analysis of randomized controlled trials. N Engl J Med 1987;316:450-455.
36. DerSimonian R, Charette J, McPeek B, et al: Reporting on methods in clinical trials. N Engl J Med 1982;306:1332-1337.
37. Peto R: Clinical trial reporting. Lancet 1996;348:894-895.
38. Cho MK, Bero LA: Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994;272:101-104.